
Baricitinib 4 mg (Olumiant) is an oral medicine used to treat certain autoimmune and inflammatory conditions, including rheumatoid arthritis, severe alopecia areata, and moderate to severe atopic dermatitis in eligible patients. It helps reduce inflammation by targeting specific immune-system pathways, which may relieve symptoms and improve daily functioning.
| Generic name | Baricitinib |
| Strength | 4 mg |
| Manufacturer | Eli Lilly and Company India |
| Package size | 7 Tablets |
| Used for | Autoimmune and inflammatory conditions |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Baricitinib is a Janus kinase (JAK) inhibitor. It works by blocking the activity of JAK1 and JAK2 enzymes, which are involved in immune-system signalling and inflammation. By reducing these signals, baricitinib helps decrease inflammation, relieve symptoms, and control disease activity.